| Intralesional HPV Vaccine for Condylomata (NCT05087849) | University of California, San Francisco | 2022-04-15 |
| An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old (NCT05056402) | Xiamen University | 2021-09-19 |
| Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age (NCT04782895) | Xiamen University | 2021-03-14 |
| Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) (NCT04537156) | Xiamen University | 2020-09-05 |
| Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts (NCT03853785) | Assiut University | 2020-02-01 |
| A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts (NCT03981822) | Verrica Pharmaceuticals Inc. | 2019-06-25 |
| Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) (NCT03935204) | Xiamen University | 2019-05-13 |
| Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) (NCT03546842) | Merck Sharp & Dohme LLC | 2018-06-29 |
| A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital Warts (NCT03158974) | ViroXis Corporation | 2017-08-01 |
| Safety and Efficacy of Immune Therapy for Condyloma (NCT03158480) | Shenzhen Second People's Hospital | 2017-06-25 |
| Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma (NCT02520986) | Ruhr University of Bochum | 2016-10-25 |
| Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine (NCT02710851) | Jun Zhang | 2016-03-24 |
| Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) (NCT02535104) | Tamir Biotechnology, Inc. | 2016-02-01 |
| Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine (NCT02405520) | Jun Zhang | 2015-03-26 |
| Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs) (NCT01796821) | G&E Herbal Biotechnology Co., LTD | 2014-08-01 |
| Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population (NCT01598779) | University of Buenos Aires | 2012-06-01 |
| Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts (NCT01532102) | Anaconda Pharma | 2012-02-28 |
| Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile (NCT01483794) | Universidad de Valparaiso | 2011-11-01 |
| Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) (NCT00365443) | Merck Sharp & Dohme LLC | 2006-10-01 |
| An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) (NCT00090285) | Merck Sharp & Dohme LLC | 2004-09-03 |
| Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts (NCT00449982) | MediGene | 2003-07-01 |
| A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts (NCT02015260) | University of Aberdeen | 2001-09-01 |